Funding
$500,000
Models
1
Overview
Andromeda Surgical is a South San Francisco-based startup building autonomous AI-guided surgical robots, founded in 2023 by Nick Damiano (CEO) and Kartik Tiwari (CTO) through Y Combinator's Summer 2023 batch. The company's software-first platform uses off-the-shelf robotic arms paired with proprietary AI-driven localization and navigation to augment surgeons during natural orifice procedures, starting with HoLEP (holmium laser enucleation of the prostate). Andromeda completed the world's first robotic-assisted HoLEP procedure in 2024 and is running the ASTRA clinical trial, with partnerships including Richard Wolf and Quanta System.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
DEPLOY Intelligence
Market intelligence for physical AI
Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.
Key facts
CEO
CTO
YC Batch
Revenue
First procedure
Clinical trial
Partners
Investors
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Andromeda Surgical on the deployment map
Where Andromeda Surgical's robots are verified operating. Explore the deployment map by place and type.
Relationships
Current leadership (2)
- Nick Damiano CEO & Co-founderreported, not verified
- Kartik Tiwari CTO & Co-founderreported, not verified
Founders (2)
- Nick Damianocofounder
- Kartik Tiwaricofounder
Safety record
No incidents on record for Andromeda Surgical.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
Andromeda Surgical in third-party press
Peer companies
- Johnson & Johnson3 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
- Stryker2 models
Financial state
- Reporting basis
- private_reported
- Revenue disclosed
- $1500000 (private_reported)
- Lifecycle stage
- early
- Counterparty risk class
- moderate
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (1)
- Seed2023-08-29
$500,000(reported)
Investors: Y Combinator, WestWave Capital, Attack Capital
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 6, 2026
Added to the verified registry
Sources (1)
Common questions
- What is Andromeda Surgical?
- Andromeda Surgical is a South San Francisco-based startup building autonomous AI-guided surgical robots, founded in 2023 by Nick Damiano (CEO) and Kartik Tiwari (CTO) through Y Combinator's Summer 2023 batch. The company's software-first platform uses off-the-shelf robotic arms paired with proprietary AI-driven localization and navigation to augment surgeons during natural orifice procedures, starting with HoLEP (holmium laser enucleation of the prostate). Andromeda completed the world's first robotic-assisted HoLEP procedure in 2024 and is running the ASTRA clinical trial, with partnerships including Richard Wolf and Quanta System.
- What does Andromeda Surgical make?
- Andromeda Surgical has 1 robot model on the DEPLOY registry: Andromeda Surgical Robot (Andromeda Surgical builds physical robots).
- Is Andromeda Surgical publicly traded?
- No. Andromeda Surgical is privately held and not publicly traded, per the DEPLOY registry.
- Who competes with Andromeda Surgical?
- On the DEPLOY registry, peer companies to Andromeda Surgical building in the same form factors include Johnson & Johnson, Intuitive Surgical, LEM Surgical, MicroPort MedBot.
- Who is the CEO of Andromeda Surgical?
- Nick Damiano is the ceo of Andromeda Surgical, per the DEPLOY registry.
- How can I invest in Andromeda Surgical?
- Andromeda Surgical is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today. It has raised $500,000 in disclosed funding.
- Where is Andromeda Surgical headquartered?
- Andromeda Surgical is headquartered in South San Francisco, CA, USA.
- How much funding has Andromeda Surgical raised?
- Andromeda Surgical has raised approximately $500K in disclosed funding on record in the DEPLOY registry.
- Who owns Andromeda Surgical?
- Andromeda Surgical is privately held and venture-backed ($500,000 raised); ownership sits with its founders and private investors.
- Where does Andromeda Surgical operate robots?
- Andromeda Surgical is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.
- Is Andromeda Surgical a top robotics company?
- On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Andromeda Surgical ranks in roughly the top 83% of companies tracked by the registry.
- Is Andromeda Surgical safe?
- Andromeda Surgical has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-07-09
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-09
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Andromeda Surgical.Peer companies
- Johnson & Johnson3 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
- Stryker2 models
In the press
Recent coverage mentioning Andromeda Surgical from third-party publications. Automatically surfaced; not part of the verified registry record.
Andromeda Surgical: Funding, Team & Investors
Andromeda Surgical completed the world's first robotic-assisted HoLEP procedure at Universidad Catolica in Chile, with $1.5M revenue and partnerships with Richard Wolf and Quanta…
Andromeda Surgical: Autonomous surgical robots
Andromeda Surgical launched in YC Summer 2023 batch, building autonomous surgical robots that use AI to make surgery cognitively easier, starting with HoLEP (prostate enucleation)…
Our Investment in Andromeda Surgical: AI Robots for surgery
Attack Capital announced investment in Andromeda Surgical, noting founders Nick Damiano (Zenflow, Avail Medsystems) and Kartik Tiwari (Starsky Robotics) combine medtech and…
Machine-readable surfaces
- Markdown mirror: /companies/andromeda-surgical.md
- RSS feed: /companies/andromeda-surgical/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/bf2d14eb-db65-4c5f-9110-dddcb2c08c70
- Revision history: /companies/andromeda-surgical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Johnson & Johnson3 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
- Stryker2 models
Video
Abi has been created with Australian aged care providers to bring joy and personalised companionship to residents, improving wellbeing and enhancing care team capacity. Abi uses advanced AI and machine learning models
In this episode, Omar Khateeb sits down with Nick Damiano, CEO and Co-Founder of Andromeda Surgical, to explore the future of autonomous surgery and software-fi
This week, we interviewed Nick Damiano. Nick is a serial entrepreneur focused on solving unmet needs to improve patient care. He is currently CEO & Founder of A
Learn more about AUA Innovation Nexus at https://www.auanexus.org!
He’s turning an iPad into a surgical cockpit—and launching semi-autonomous surgery from New Zealand to the world. 🎧 Listen On: Spotify: https://spoti.fi/4is21
In this episode of 8Spotlight, we sit down with Nick Damiano, founder of Andromeda Surgical, to discuss the future of autonomous surgery. Nick shares how his te
In this week’s episode of the DeviceTalks Weekly Podcast, Nick Damiano, co-founder and CEO of Andromeda Surgical, previews his talk at DeviceTalks West by intro
Reality vs attention
Andromeda Surgical draws attention at the 20th percentile but verifies reality at the insufficient-data level among surgical robots.
6-month trend
Analysis
Funding runway warrants monitoring: last known round 35 months ago.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Jul 19, 2026